October 4, 2024: Lawsuits Against Eli Lilly Escalate as Trulicity Side Effect Concerns Grow The number of lawsuits targeting GLP-1 drug manufacturers, including Eli Lilly, the maker of Trulicity, saw a 20% increase between August and September
.,WangW,ChenT,XuH,RenB,ChengX,QiRChenCCurcumin-loaded solid lipid nanoparticles enhanced anticancer efficiency in breast cancer.2018;23(7):1578 84
318,319 ZIP6 (also known as LIV-1), was initially recognized as an estrogen-mediated gene since 1988
Understanding potential side effects and interactions helps ensure safe, effective supplementation
Diabetic retinopathy: current understanding, mechanisms, and treatment strategies
Injections vs Infusions: What to Consider At Ayafusion, NAD+ therapy is available in two formats: Injections: quick, convenient, useful for maintenance Infusions: higher dosing, slower delivery, deeper support A More Realistic Expectation NAD+ therapy is not a quick fix and is not designed to create a sudden surge of energy